Spark Therapeutics Stock
-
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
Cons
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| United Therapeutics | -1.950% | 4.439% | 11.379% | 69.931% | 14.533% | 143.725% | 198.415% |
| Ionis Pharmaceuticals Inc. | 0.830% | 0.621% | -7.530% | 144.957% | -4.591% | 96.634% | 69.428% |
| Novocure Ltd | -2.330% | -10.373% | -20.883% | -44.694% | -19.347% | -83.519% | -91.924% |
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December

